Small drug package system to undergo overhaul

The Korea Food and Drug Administration will unveil its plan to ameliorate the controversial small drug package system, under which drug makers are obliged to produce mall-package drugs as much as 10% of the total outputs.

The KFDA will investigate the exact demand of small package drugs across the nation to reduce the obligatory production ratio for given medicines.

The pharmaceutical ind...